Company overview
BRN
80010000719848
Name
Oncopharm (U) Limited
Entity type
Private Company Limited By Shares
Paid up capital
UGX 99,900,000
Authorized capital
UGX 99,900,000
Industry name
Other human health activities
Phone
+256778419677
Status
Registered
Incorporation date
23 February 2015
Address
Village A, Kamwokya I, Central Division, Kampala, Central
Country
Uganda
Primary goods traded
| Name | Role | Nationality | Capital | Address |
|---|---|---|---|---|
| Takeda Uganda Limited | Shareholder | — | UGX 33,300,000 | Brown Flats A & C, Naguru II, Nakawa Division, Kampala, Central |
| Uwiringiye Ruth | Shareholder | Ugandan | UGX 33,300,000 | Brown Flats F, Naguru II, Nakawa Division, Kampala, Central |
| Omoding Abrahams | Shareholder | Ugandan | UGX 33,300,000 | Kimwanyi, Kimwanyi, Kira Division, Wakiso, Central |
| Okalang Law Chambers | Secretary | — | — | Jambula Zone B, Bugolobi, Nakawa Division, Kampala, Central |
| Muhanguzi Nelson | Director | Ugandan | — | Kinawataka A, Mbuya I, Nakawa Division, Kampala, Central |
| Uwiringiye Ruth | Director | Ugandan | — | Brown Flats F, Naguru II, Nakawa Division, Kampala, Central |
| Omoding Abrahams | Director | Ugandan | — | Buwate ‘A’, Kira, Kira Division, Wakiso, Central |
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 30 June 2025 | UG | 30049000000 | Herticad Sol 440Mg | Oncopharm U Limited | UG | Anabion Pharmaceutical Ltd | $408,000.00 | |
| 30 June 2025 | UG | 30049000000 | Bevalast Sol 400Mg | Oncopharm U Limited | UG | Anabion Pharmaceutical Ltd | $380,000.00 | |
| 30 June 2025 | UG | 30049000000 | Acellbia Sol 500Mg | Oncopharm U Limited | UG | Anabion Pharmaceutical Ltd | $284,000.00 | |
| 28 April 2025 | UG | 30049000000 | Albumin-Biopharma | Oncopharm U Limited | UG | Lc Biopharma Plasma | $245,000.00 | |
| 9 August 2025 | UG | 30049000000 | Merosain 1 Di | Oncopharm U Limited | UG | Sanba Pharma | ID | $14,285.00 |
| 9 August 2025 | UG | 30049000000 | Merosan 0.5 Di | Oncopharm U Limited | UG | Sanba Pharma | ID | $8,043.00 |
| 9 August 2025 | UG | 30049000000 | Sanbecleneks 200Mg | Oncopharm U Limited | UG | Sanba Pharma | ID | $7,272.00 |
| 9 August 2025 | UG | 30049000000 | Pelastin | Oncopharm U Limited | UG | Sanba Pharma | ID | $6,112.00 |